Associate Research Fellow, Drug Safety Research and Development, Pfizer, Inc.
BIOGRAPHY
Nonclinical COVID-19 Vaccine Development During a Pandemic
Presented at:
Drug Discovery & Development Virtual Event Series 2021
Speaker
Abstract
The COVID-19 pandemic changed all of our lives in 2020. Development of a COVID-19 vaccine required some re-thinking of the standard vaccine development paradigm. The webinar will cover nonclinical development of the Pfizer-BioNTech CoVID-19 vaccine as well as some aspects specifically related to developing an mRNA vaccine and how that differed from a typical infectious disease nonclinical development program.
Learning Objectives:
1. Provide brief overview of the typical approach to infectious disease vaccine development
2. Describe approach used for COVID-19 vaccine nonclinical development during a pandemic
3. Outline some points to consider in mRNA vaccine nonclinical development
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...